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Abstract
Background: The exact mechanism underlying HIV-associated neurocognitive disorders still remains largely
unresolved. However, viral genes (for example gp120 and tat) and their effect on cytokine/chemokine expressions
have been linked with neuroinflammation. Conversely, interlekin-8 (IL-8) is a known proinflammatory chemokine
and is known to be over-expressed in human brain microvascular endothelial cells in response to gp120. In this
study, we sought to address whether HIV-1gp120 could affect IL-8 expression in astrocytes and whether the NF-B
pathway is involved in this phenomenon.
Methods: SVGA astrocytes were transfected with a plasmid expressing HIV-1 pSyn gp120 JR-FL using
Lipofectamine2000. The cells were harvested at different time points after transfection, and total cellular RNA was
used for quantification of IL-8 using a real time PCR. IL-8 protein expression was also determined in supernatants
collected at different time points after transfection. Involvement of the NF-B pathway was addressed using both
pharmacological inhibitors and an siRNA approach. In order to explore gene specificity, gp120-specific siRNAs were
designed and IL-8 expression was monitored at both mRNA and protein levels.
Results: Gp120 increased IL-8 expression both at mRNA and protein levels by 7.1 ± 1.04 and 2.41 ± 0.35 fold at
6 and 48 hours post-transfection, respectively. This increase was time-dependent and was abrogated by use of
gp120-specific siRNA. We have also shown that the NF-B pathway is involved in gp120-mediated IL-8
overexpression as IKK-2 and IKKb inhibitors inhibited IL-8 expression by 63.5% and 57.5%, respectively at the mRNA
level, and by 67.3% and 58.6% at the protein level. These results were also confirmed with use of NF-B-specific
siRNA.
Conclusion: These results indicate that gp120 can modulate expression of a pro-inflammatory chemokine (IL-8) in
astrocytes in a time-dependent manner with significant up-regulation at different times. This phenomenon is
specific and is mediated by the NF-B pathway.
Background
Human immunodeficiency virus (HIV-1) can cause
infection in the central nervous system (CNS) of an
infected individual and is responsible for HIV-associated
neurocognitive disorder (HAND). Gp120, a surface gly-
coprotein, not only plays an important role in attach-
ment and viral entry [1-3] into host cells but is also
known to cause neurotoxicity through a variety of
mechanisms. These include oxidative stress [4], white
matter gliosis, loss of the structural integrity of blood
brain barrier (BBB) [5] and neuronal cell loss [6]. These
types of neurological damage, especially gliosis and
inflammation in the brain, have been found to correlate
with increased production of proinflammatory cyto-
kines/chemokines [7-10].
The astrocyte is a major CNS cell type and is known to
exhibit limited productive replication of the virus [11].
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brain of infected patients [12]. The viral protein gp120
has been shown to be directly correlated with increased
production of TNF-1a,I L - 1 b and IL-6; and is inversely
correlated with expression of P-glycoprotein in rat astro-
cytes [13,14]. Furthermore gp120 has also been shown to
increase IL-6 production in mixed human brain cell cul-
ture [15].
Interleukin (IL)-8 is an important chemokine, which
responds in combination with other inflammatory
mediators [16,17]. It has been reported to be increased
during brain injury and neuroinflammation [18]. HIV-1
tat has been shown to induce IL-8 in human brain-
derived endothelial cells and astrocytes [19,20]. Further-
more, IL-8 has also been reported to be involved in a
STAT1-dependent mechanism for gp120-mediated
increased IL-8 production in human brain microvascu-
lar endothelial cells [21]. Thus, together all of these stu-
dies suggest a potential role for IL-8 in HIV-associated
neuroinflammation. However, there is no direct evi-
dence as to whether gp120 would cause IL-8 expression
in astrocytes.
In this study, we sought to address the question as to
whether gp120 would affect IL-8 expression in a human
astrocytic cell line, SVGA. We also sought to address
whether the NFkB pathway is involved in this process,
and this was accomplished using NFkB inhibitors and
siRNA.
Methods
Cells and reagents
SVGA is a clone of a human fetal astrocyte cell line
(SVG) [22] and was maintained in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) and 50 μM gentamicin at 37°C in
5% CO2 environment. Lipofectamine™ 2000, and NF-kB
inhibitors (IKK-2; SC514 and IKK-b; BAY117082) were
obtained from Invitrogen Inc. (Carlsbad, CA) and Cal-
biochem (EMD Biosciences Inc., La Jolla, CA), respec-
tively. The HIVgp120 plasmid (Cat number 4598; pSyn
gp120 JR-FL) was originally developed by Drs. Park and
Seed [23], and was obtained from NIAID AIDS Reagent
Center. Gp120-specific small interfering RNA (siRNA)
was designed using SDSC Biology Workbench software,
and various sequences of the siRNA targeted against
gp120 were commercially synthesized by Ambion Inc.
(Applied Biosystems, Foster city, CA). Pre-designed
siRNA for NF-kB (P/N AM51331; id 5213) and Rel-A
(P/N 4390824; id s11914) were also purchased from
Ambion Inc. (Applied Biosystems, Foster city, CA).
Transfection
SVGA cells were transfected with Lipofectamine™ 2000
as recommend by the manufacturer. Briefly, 1 × 10
6
cells were transiently transfected with 2 μg gp120 and
4 μl of lipofectamine in 1 ml serum-free medium for a
period of 5 hours. The cells were harvested and total
RNA was extracted using RNeasy kit from Qiagen
(Valencia, CA). IL-8 expression was measured at time
points of 6, 12, 24, 48 and 72 hours after the transfec-
tion. For NF-kB inhibition experiments, the cells were
treated with 10 μM antagonist for 24 hours prior to the
transfection. siRNA transfection was also performed
using Lipofectamine™ 2000 and incubation for 48 hrs
prior to gp120 transfection. Briefly, 50 nmoles of siRNA
was transfected into each well containing 1 × 10
6 astro-
cytes in serum-free media. The transfection media was
replaced after 24 hours with fresh DMEM supplemented
with 10% FBS and the cells were incubated for 24 hours.
Later, the cells were transiently transfected with gp120
as described above and the IL-8 levels were monitored
6 hours post-transfection. Inhibition of IL-8 expression
was calculated as a percentage of expression in controls
that were either mock-transfected or transfected with
scrambled siRNA.
Real time RT-PCR and IL-8 protein assay
Real time reverse transcriptase polymerase chain reac-
tion (RT-PCR) was used to measure IL-8 mRNA using
forward primer (5’ CTC TTG GCA GCC TTC CTG
ATT 3’), reverse primer (5’ TAT GCA CTG ACA TCT
AAG TTC TTT AGC A 3’), and probe (5’ FAM-CTT
GGC AAA ACT GCA CCT TCA CAC AGA-3’ BHQ)
in a Bio-Rad iCycler. Total RNA was extracted using
RNeasy kit (Qiagen, Valencia, CA) as described in the
manufacturer’s protocol. Reverse transcription and
amplification was done using 150 ng RNA as template
in 25 μl reaction volume containing reverse transcrip-
tase, primers, probe, DNA polymerase and other
reagents. The reaction conditions included reverse tran-
scription at 50°C for 30 min, initial PCR activation at
95°C for 15 min and 50 cycles of denaturation at 95°C
for 30 sec and annealing at 61°C for 30 sec. Separate
hypoxanthine-guanine phosphoribosyl-transferase
(HPRT - house-keeping gene) amplification was used
determine fold difference in expression. The data was
analyzed using the equation 2
-ΔΔCT method as described
previously [24].
Cell culture supernatant was collected after the trans-
fection at different times and IL-8 protein concentra-
t i o n sw e r ea n a l y z e du s i n gaB i o - P l e xS y s t e m( L i f e
Science Research, Hercules, CA). The protein expression
was measured by comparing the values with the 5PL-
standard curve using Bio-Plex Manager 5.0 software.
Statistical analysis
Data are expressed in mean ± SE for 3 experiments with
each experiment done in triplicates. The statistical
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p value ≤ 0.05 was considered significant.
Results
HIV-1 gp120 induces the expression of IL-8 in time
dependent manner
Interleukin- (IL-) 8 is a major pro-inflammatory chemo-
kine, which has been associated with neuroinflammatory
mechanisms as well. However, what role gp120 plays in
the expression levels of IL-8 is still unclear. Firstly, we
wanted to ascertain whether astrocytes increase IL-8
expression upon gp120 transfection. SVGA cells were
transfected with a gp120-expressing plasmid using Lipo-
fectamine2000 reagent. Our transfection efficiency has
been between 55 and 70%, which was confirmed with
GFP transfection followed by analysis using FACScanto
flowcytometer (data not shown). IL-8 mRNA and pro-
tein expressions were monitored at 6, 12, 24, 48 and
72 hrs post-transfection (Figure 1). Peak IL-8 mRNA
level was observed at 6 hrs (14.9 ± 3.27 fold) and this
diminished in a time-dependent fashion from this peak
level. IL-8 mRNA was found to be 7.1 ± 1.04, 4.3 ±
0.89, 5.5 ± 1.9 and 2.1 ± 0.14 folds after 12, 24, 48 and
72 hour post-transfection, respectively (Figure 1A).
We further measured the protein expression in super-
natants collected at different times after transfection
with gp120. There was significant increase in IL-8
protein in gp120-transfected astrocytes at 6 hours as
compared to mock-transfected control (279.7 ± 22.6 vs
183.9 ± 22.6 pg/ml). The concentration gradually
increased in both control and gp120-transfected cells.
However, gp120-transfected cells showed a much higher
and significant increase in IL-8 expression with 407.8 ±
3.7, 464.2 ± 39.5, 700.8 ± 101.5 and 1022.7 ± 232.9 pg/
ml at 12, 24, 48 and 72 hours, respectively (Figure 1B).
During these times, IL-8 expression was 1.52 to 2.41
fold higher in gp120-transfected cells as compared to
those in control wells and the differences between
gp120 and control were statistically significant (p ≤
0.05) at 6, 12, 24 and 48 hours post-transfection.
Gp120-specific small interfering RNA (siRNA) significantly
abrogated IL-8 expression
In next series of experiments, we sought to determine
whether this IL-8 over-expression was specific to gp120.
For the purpose, we designed 4 siRNA sequences for
g p 1 2 0a ss h o w ni nF i g u r e2 A .T h es i R N A sw e r et r a n s -
fected into SVGA using Lipofectamine2000 for 48 hours
prior to gp120 transfection. mRNA and protein levels of
IL-8 were estimated as mentioned before. All of them
except siRNA-3 efficiently silenced gp120-mediated IL-8
expression to different degrees, both at mRNA and pro-
tein levels. SiRNA1, 2 and 4 inhibited by 47, 60 and 57%
IL-8 expression at the mRNA level (6 hours post-trans-
fection) and by 56, 83 and 74% inhibition at the protein
level (48 hours post-transfection). As shown in Figure
2 Ba n d2 C ,s i R N A - 2w a st h em o s tp o t e n ta ti n h i b i t i n g
gp120-mediated IL-8 expression, both at the mRNA and
protein levels. However, inhibitions at protein levels
were higher than those at mRNA levels.
gp120 mediated increase in IL-8 expression was
abrogated with NF-B specific antagonists and siRNA
Our next question was to determine whether the NF-B
pathway was involved in the gp120-mediated increase in
IL-8 levels. We tested this by using two chemical inhibi-
tors and two unique commercially available siRNAs.
SVGA astrocytes were treated with 10 μMo fI K K - 2
(SC514) and IKKb (BAY11-7082) inhibitors for 24 hours
prior to transfection with gp120, and maintained with
inhibitors throughout the experiment. IL-8 mRNA and
protein expressions were monitored 6 and 48 hours
after transfection respectively. Both SC514 and BAY11-
7082 successfully inhibited gp120-mediated expression
of IL-8 mRNA by 27.5 ± 11.5% and 42.5 ± 15.9%
respectively, (Figure 3A). Similarly, IL-8 protein level
was also reduced by 67.3 ± 12.6% and 58.6 ± 15.4%,
respectively by SC514 and BAY11-7082 (Figure 3B).
We also tested 2 commercially available siRNAs
against NF-B1 and Rel-A to determine their effects on
gp120-mediated IL-8 regulation. Specific siRNA for
NFkB-1 and Rel A were transfected into astrocytes 48
hours prior to gp120 transfection, and mRNA/protein
expressions were measured as described above. Both
NF-B- and Rel-A-specific siRNA blocked >55 and
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Figure 1 Gp120-mediated increased expression of IL-8 in SVGA
astrocyte cells.1×1 0
6 SVGA astrocytes were transfected with 1
μg gp120 DNA for 5 hours, using a lipofection method. Total RNA
was extracted from cells at 6, 12, 24, 48 and 72 hours after
transfection, and culture supernatant was collected at the same
times. IL-8 mRNA was determined using real time PCR whereas
protein was measured using a Bio-plex method. Expressions of IL-8
at the mRNA (A) level were compared between gp120-transfected
cells and those with empty plasmids, and are presented as fold
change. (B) IL-8 protein levels are shown as pg/ml culture
supernatant and were compared between gp120-transfected and
control cells transfected with empty plasmid. Each bar represents
mean ± SE for 3 independent experiments, with each experiment
done in triplicate. Student’s t test was used for statistical analysis
and statistical significance is denoted as * (p value ≤ 0.05).
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(Figure 3C &3D). These experiments unambiguously
confirm the results from chemical inhibition experi-
ments that gp120-mediated increases in IL-8 expression
are dependent on the NF-B pathway.
Discussion
HIV-1 glycoprotein 120 (gp120) plays an essential role
in viral attachment and entry into host cells. In this
study, we showed that gp120 induces IL-8 expression at
both RNA and protein level in a time-dependent man-
ner in astrocytes. Several earlier reports from different
laboratories have shown the neurotoxic potential of
gp120 during HIV-1 infection [25,26]. This phenomenon
has also been shown to be mediated via oxidative stress
[13,27], and has also been shown to correlate with
increased production of TNF-a,I L - 1 b and IL-6
[9,28,29]. Recently, an elegant report by Li and co-work-
ers showed indirect evidence for a role for gp120 in IL-
8 over-expression, wherein they showed reduced IL-8
production in astrocytes when these were infected with
gp120-deleted virion compared to those cells that were
infected with wild-type [12].
I nt h i ss t u d yw eh a v ef o rt h ef i r s tt i m es h o w nt h a t
gp120 is involved in IL-8 up-regulation in time-depen-
dent manner, and that this effect is specific. This was
A small interfering RNA (siRNA) sequences targeted for gp120. 
siRNA Sequences* 
gp120 siRNA-1  5’-UGU GAC UGA GCA CUU CAA Ctt-3’ 
gp120 siRNA-2 5’-UGA CAC CCU GAA GCA GAU Utt-3’
gp120 siRNA-3  5’-GCA GAU UGU GAU CAA GCU Gtt-3’  
gp120 siRNA-4  5’-AGC AUA UGA UAC AGA GGU Att-3’ 
* The sequences shown above are sense strands of the siRNA 
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Figure 2 Inhibition of gp120-induced IL-8 expression by
gp120-specific siRNA. Four different siRNAs for gp120 were
designed using the Ambion siRNA designing tool, and were
commercially synthesized by Ambion Inc (A). 1 × 10
6 astrocytes
were transfected with 50 nM of siRNA for 48 hours followed by
gp120 transfection. mRNA (B) and protein (C) expressions of IL-8
were measured at 6 and 48 hours post gp120 transfection,
respectively. mRNA expression is represented as fold change
between gp120 transfected cells and cells transfected with empty
plasmid. The protein expressions are presented as absolute
concentrations (pg/ml). Each bar represents mean ± SE for 3
independent experiments with each experiment done in triplicate.
Student’s t test was used for statistical analysis and statistical
significance is denoted as * (p value ≤ 0.05).
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Figure 3 Inhibition of gp120-mediated IL-8 expression by
pharmacological inhibitors and siRNAs specific for the NF-B
pathway. SVGA astrocytes were treated with 10 μM of SC514 (IKK-2
Inhibitor) and BAY11-7082 (IKKb) for 24 hours followed by gp120
transfection in the presence of inhibitor. The appropriate inhibitor
concentration was maintained throughout experiment. The relative
IL-8 mRNA expressions (A) and protein expressions (B) are expressed
as a percentage of levels in inhibitor-treated gp120-transfected cells
relative to untreated cells. For siRNA experiments, SVGA astrocytes
were transfected with NF-B pathway-specific siRNAs for 48 hours
followed by gp120 transfection. mRNA and protein levels were
determined at 6 and 48 hours post-transfection, respectively.
Inhibition of IL-8 mRNA (C) and protein (D) are presented as a
percentage of IL-8 expression in gp120-transfected cells. Each bar
represents mean ± SE for 3 independent experiments with each
experiment done in triplicates. Student’s t test was used for
statistical analysis and statistical significance is denoted as * (p value
≤ 0.05).
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approach has evolved into an important tool for gene-
silencing studies in mammalian systems during recent
years, and a variety of siRNAs have been used to knock-
down various genes like gag, tat, pol and integrase, and
to inhibit HIV replication [30-34]. However, no study
has reported inhibition of IL-8 or any other cytokine/
chemokine using the siRNA approach. In order to assess
whether IL-8 induction is indeed a result of gp120 intro-
duction into cells, we used various siRNAs in order to
knockdown gp120 expression. In view of significant
inhibition observed both at RNA and protein levels, we
conclude that IL-8 induction observed in gp120-trans-
fected cells is gene specific.
In this study, we have shown that gp120-mediated
increases in IL-8 expression could be inhibited by speci-
fic NF-B pathway inhibitors, implying role for this
pathway in IL-8 production. Earlier studies have already
shown a role for NF-B activation in IL-8 production in
asthmatic patients [35]. Using various mutational and
deletion analysis it has been proved that certain promo-
ter elements in NF-B complex play a potential role in
inducing the IL-8 promoter, which emphasizes the
important role of NF-B in IL-8 transcription [36,37].
SC514 is a novel inhibitor of NF-B, which targets IKK-
2 [38], whereas BAY11-7082 blocks NF-B activation by
inhibiting TNF-a-induced phosphorylation of IKKb [39].
IkKb acts as a negative regulator of the NF-Bp a t h w a y
and prevents NF-B activation. Phosphorylation of IkKb
leads to activation of NF-B, and activated NF-B later
incorporates into the nucleus and leads to a downstream
cascade. In our study, we observed that inhibition of
NF-B activation by targeting IkKb leads to partial abro-
gation of gp120-mediated IL-8 expression. Involvement
of the NF-B pathway was also confirmed by silencing
the NF-B gene, which resulted in partial-to-near-com-
plete restoration of gp120-mediated IL-8 expression to
basal level in astrocytes.
In summary, we have shown that gp120 induces up-
regulation of IL-8 in astrocytes, and that the NF-kB
pathway appears to be predominantly responsible for
this since direct interference with this pathway disrupts
gp120-dependent induction of IL-8. We have also
shown that gp120-specific siRNA abrogates this effect,
suggesting that IL-8 over-expression is gp120 specific.
These data suggest that IL-8 may be a potential target
for intervention to reduce or ameliorate neuroinflamma-
tion, and could also become an important adjunct thera-
peutic strategy for future consideration.
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